N/A
Completed N=179
Motivational Interviewing and Guided Opioid Tapering Support to Promote Postoperative Opioid Cessation
Opioid Cessation
Source: ClinicalTrials.gov NCT03659734 ↗
Enrolled (actual)
179
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcomePrimary: Time to Opioid Cessation — 28; 25 days
Summary
The purpose of this study is to evaluate the relative efficacy of enhanced usual care versus motivational interviewing and guided opioid tapering support to promote opioid cessation after total hip or knee replacement surgery.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Time to Opioid Cessation |
28; 25 | — |
| SECONDARY Number of Participants With Opioid Misuse (Postoperative COMM Score Greater Than or Equal to 9) |
20; 17 | — |
Eligibility Criteria
Inclusion Criteria
- Planning to undergo surgery
- English speaking
- Ability and willingness to complete questionnaires and assessments
- Scheduled for total hip, knee, or shoulder replacement
- Preoperative opioid use and opioid use 14 days after surgery to increase the likelihood of delayed opioid cessation.
- Not under the care of a current pain management provider
Exclusion Criteria
- Any conditions causing inability to complete assessments
- Known pregnancy
- Elevated suicidality
- Enrollment in conflicting perioperative trial
Data sourced from ClinicalTrials.gov (NCT03659734). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.